Free radicals generated by ionizing radiation signal nuclear translocation of p53

Cell Growth and Differentiation

Volumn 8, Issue 9, 1997, Pages 941-949

  Martinez, J D ^a   Pennington, M E ^a   Craven, M T ^a   Warters, R L ^b   Cress, A E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FREE RADICAL; MITOMYCIN C; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; GENOME; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL NUCLEUS; FREE RADICALS; GAMMA RAYS; HUMANS; INTRACELLULAR FLUID; MICE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0030967932     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 357: 453-456, 1991.
2. Smith. M. L., and Fornace, A. J., Jr. The two faces of tumor suppressor p53. Am. J. Pathol., 148: 1019-1022, 1996.
3. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
4. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 74: 1815-1823, 1994.
5. Kastan, M. B., Zhan, Q, El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, J., AJ. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 77: 587-597, 1992.
6. Fornace, A. J., Nebert, D. W., Hollander, M. C., Leuthy, J. D., Papathanasiou, M., Fargnoli, J., and Holbrook, N. J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol., 9: 4196-4203, 1989.
7. Zhan, Q., Bae, I., Kastan, M. B., and Fornace, A. J., Jr. The p53-dependent γ-ray response of GADD45. Cancer Res., 54: 2755-2760, 1994.
8. Nacht, M., Strasser, A., Chan, Y. R., Harris, A. W., Schlissel, M., Bronson, R. T., and Jacks, T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev., 10: 2055-2066, 1996.
9. Guidos, C. J., Williams, C. J., Grandal, L, Knowles, G., Huang, M. T., and Danska, J. S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev., 10: 2038-2054, 1996.
10. Zhan, Q., Carrier, F., and Fornace, A. J., Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13: 4242-4250, 1993.
11. Bjelogrlic, N. M., Makinen, M., Stenback, F., and Vahakangas, K. Benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis (Lond.), 15: 771-774, 1994.
12. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
13. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
14. Reich, N. C., and Levine, A. J. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (Lond.), 308: 199-201, 1984.
15. Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C., and Beach, D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA, 87: 4766-4770, 1990.
16. Sherley, J. L. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem., 266: 24815-24828, 1991.
17. 1-, cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev., 10: 934-947, 1996.
18. Martinez, J., Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev., 5: 151-159, 1991.
19. Shaulsky, G., Goldfinger, N., Tosky, M. S, Levine, A. J., and Rotter, V. Nuclear localization is essential for the activity of p53 protein. Oncogene, 6: 2055-2065, 1991.
20. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation, Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
21. Davidoff, A. M., Pence, J. C., Shorter, N. A., lglehart, J. D., and Marks, J. R. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene, 7: 127-133, 1992.
22. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53. Cell, 71: 875-886, 1992.
23. Chen, C. Y., Oliner, J. D., Zhan, Q., Fornace, A. J., Jr, Vogelstein, B., and Kastan, M. B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA, 91: 2684-2688, 1994.
24. Smoluk, G. D., Fahey, R. C., Calabro-Jones, P. M., Aguilera, J. A., and Ward, J. F. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection. Cancer Res., 48: 3641-3647, 1988.
25. Ward, J. F., Blakely, W. F., and Joner, E. I. Mammalian cells are not killed by DNA single-strand breaks caused by hydroxyl radicals from hydrogen peroxide. Radiât. Res., 103: 383-392, 1985.
26. Ramachandran, C., Samy, T. S., Huang, X. L., Yuan, Z. K., and Krishan, A. Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells. Biochem. Pharmacol., 45: 1367-1371, 1993.
27. Iyer, V. N., and Szybalski, W. A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc. Natl. Acad. Sci. USA, 50: 355-362, 1963.
28. Borowy-Borowski, H., Lipman, R., and Tomasz, M. Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry, 29: 2999-3006, 1990.
29. Polla, B. S., Donati, Y., Kondo, M., Tochon-Danguy, H. J., and Bonjour, J. P. Protection from cellular oxidative injury and calcium intrusion by N-(2-mercaptoethyl)-1,3-propanediamine, WR 1065. Biochem. Pharmacol., 40: 1469-1475, 1990.
30. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., and Liu, L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (Washington DC), 226: 466-468, 1984.
31. Huxham, I. M., Barlow, A. L., Lewis, A. D., Plumb, J., Mairs, R. J., Gaze, M. N., and Workman, P. Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysis. Int. J. Cancer, 59: 94-102, 1994.
32. Sweigert, S. E., Eguchi-Kasai, K., Warters, R. L, and Dethlefsen, L. A. Repair of DNA single- and double-strand breaks in proliferating and quiescent murine tumor cells. Int. J. Radiat. Biol., 56: 253-264, 1989.
33. Warters, R. L., and Lyons, B. W. Induction and repair of double-strand breaks in the replicating DNA of HeLa cells. Radiat. Res., 134: 337-342, 1993.
34. Cornforth, M. N., and Bedford, J. S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science (Washington DC), 227: 1589-1591, 1985.
35. Hittleman, W. N., and Pollard, M. A comparison of the DNA and chromosome repair kinetics after irradiation. Radiat. Res., 92: 497-509, 1982.
36. Moll, U. M., LaQuaglia, M., Benard, J., and Riou, G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA, 92: 4407-4411, 1995.
37. Moll, U. M., Riou, G., and Levine, A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA, 89: 7262-7266, 1992.
38. Miller, C. W., Chumakov, A., Said, J., Chen, D. L., Aslo, A., and Koeffler, H. P. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. Oncogene, 8: 1815-1824. 1993.
39. Crook, T., Marston, N. J., Sara, E. A., and Vousden, K. H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79: 817-827, 1994.
40. Casey, G., Lo-Hsueh, M., Lopez, M. E., Vogelstein, B., and Stanbridge, E. J. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6: 1791-1797, 1991.
41. Harlow, E., Crawford, L V., Pim, D. C., and Williamson, N. M. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol., 39: 861-869, 1981.
42. Hinds, P. W., Finlay, C. A., Frey, A. B., and Levine, A. J. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol., 7: 2863-2869, 1987.